Difference between revisions of "Part:BBa K5398601"

(SDS-PAGE)
 
(20 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
===Introduction===
 
===Introduction===
<p>Mussel foot protein type 6 (Mfp6)(BBa_K5398601), which has a molecular weight of 13.8 kDa, is a protein found in the byssal gland cells of mussels. It belongs to the family of mussel foot proteins and plays a crucial role in maintaining the reducing conditions necessary for optimal wet adhesion in marine mussels. Mfp6(BBa_K5398601) is particularly rich in cysteine, a sulfur-containing amino acid that can form stable structures in mussel adhesion proteins and provide antioxidant protection. This antioxidant property helps prevent second-oxidation of dopamine (DOPA) residues in adhesion proteins, thereby maintaining their adhesive function. </p>
+
<p>Mussel foot protein type 6 (Mfp6)(BBa_K5398601), which has a molecular weight of 13.8 kDa, is a protein found in the byssal gland cells of mussels. It belongs to the family of mussel foot proteins and plays a crucial role in maintaining the reducing conditions necessary for optimal wet adhesion in marine mussels. Mfp6(BBa_K5398601) is particularly rich in cysteine, a sulfur-containing amino acid that can form stable structures in mussel adhesion proteins and provide antioxidant protection. This antioxidant property helps prevent second-oxidation of Levodopa (L-DOPA) residues in adhesion proteins, thereby maintaining their adhesive function. </p>
<p>During the adhesion process of mussels, Mfp6(BBa_K5398601) may work in conjunction with other foot proteins, such as Mfp3 and Mfp5, which are rich in DOPA and are key factors in the adhesive strength of mussel adhesion proteins. Mfp6(BBa_K5398601), through its antioxidant properties, helps protect dopamine residues at the initial stage of adhesion, thus maintaining the protein's adhesive ability. In addition, Mfp6(BBa_K5398601) may also regulate the tautomeric balance of adhesion proteins, further affecting adhesion performance.</p>
+
<p>During the adhesion process of mussels, Mfp6(BBa_K5398601) may work in conjunction with other foot proteins, such as Mfp3 and Mfp5, which are rich in L-DOPA and are key factors in the adhesive strength of mussel adhesion proteins. Mfp6(BBa_K5398601), through its antioxidant properties, helps protect L-DOPA residues at the initial stage of adhesion, thus maintaining the protein's adhesive ability. In addition, Mfp6(BBa_K5398601) may also regulate the tautomeric balance of adhesion proteins, further affecting adhesion performance.</p>
 
===Usage and Biology===
 
===Usage and Biology===
<p>Mfp6(BBa_K5398601) is a improtant part of <b>the Tyrosinase Catalysis System</b>.When tyrosinase TyrVs(BBa_K5398600) causes excessive oxidation of tyrosine on the fusion protein TRn4-Mfp5(BBa_K5398020) to form dopaquinone, the Mfp6 protein(BBa_K5398601) can reduce the excessively oxidized dopaquinone back to DOPA, thereby enhancing the adhesive performance of the fusion protein TRn4-Mfp5(BBa_K5398020).</p>
+
<p>Mfp6(BBa_K5398601) is a improtant part of <b>the Tyrosinase Catalysis System</b>.When tyrosinase TyrVs(BBa_K5398600) causes excessive oxidation of tyrosine on the fusion protein TRn4-Mfp5(BBa_K5398020) to form dopaquinone, the Mfp6 protein(BBa_K5398601) can reduce the excessively oxidized dopaquinone back to L-DOPA, thereby enhancing the adhesive performance of the fusion protein TRn4-Mfp5(BBa_K5398020).</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 21: Line 21:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-zuoyongjilipng.webp" width="400" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-mfp5.webp" width="400" height="auto" alt="Protein purification">
 
         <p><b>Fig. 1 | Mechanism of action.</b></p>
 
         <p><b>Fig. 1 | Mechanism of action.</b></p>
 
     </div>
 
     </div>
Line 30: Line 30:
 
===Plasmid Construction===
 
===Plasmid Construction===
 
<p>The Mfp6 sequence(363 bp) was cloned from the pETDuet-1-Mfp6 vector using a polymerase chain reaction(PCR) method. Specific primers were synthesized for PCR amplification(Table 1). The forward primer was designated as Mfp6-top, and the reverse primer as Mfp6-bottom. These primers, along with 2×Phanta Max Master Mix (Dye Plus), were used in a PCR reaction for 30 cycles with a temperature profile of 15 sec at 95°C, 15 sec at 56°C, and 1 min at 72°C.</p>
 
<p>The Mfp6 sequence(363 bp) was cloned from the pETDuet-1-Mfp6 vector using a polymerase chain reaction(PCR) method. Specific primers were synthesized for PCR amplification(Table 1). The forward primer was designated as Mfp6-top, and the reverse primer as Mfp6-bottom. These primers, along with 2×Phanta Max Master Mix (Dye Plus), were used in a PCR reaction for 30 cycles with a temperature profile of 15 sec at 95°C, 15 sec at 56°C, and 1 min at 72°C.</p>
<p>Similarly, the pET-28a(+) sequence(5725 bp) was cloned from the pET-28a(+)-TRn4-Mfp5 vector. The forward primer was pET-28a(+)-top and the reverse primer was pET-28a(+)-bottom(Tab. 1). Polymerase Chain Reaction(PCR) was performed for 30 cycles with a temperature profile of 95°C for 15 sec, 67°C for 15 sec, and 72°C for 1 min.</p>
+
<p>Similarly, the pET-28a(+) sequence(5725 bp) was cloned from the pET-28a(+)-TRn4-Mfp5 vector. The forward primer was pET-28a(+)-top and the reverse primer was pET-28a(+)-bottom(Table 1). Polymerase Chain Reaction(PCR) was performed for 30 cycles with a temperature profile of 95°C for 15 sec, 67°C for 15 sec, and 72°C for 1 min.</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 48: Line 48:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <p><b>Tab. 1 | Details of Plasmids、Fragments and Primers.</b></p>
+
         <p><b>Table 1 | Details of Plasmids、Fragments and Primers.</b></p>
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/result-mfp6.webp" width="800" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/result-mfp6.webp" width="800" height="auto" alt="Protein purification">
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
<p>The purified fragments were analyzed by electrophoresis on 1% agarose gels stained with ethidium bromide with YeaRed Nucleic Acid Gel Stain(Fig. 2).  The Mfp6 fragment was inserted into the pET28a(+) vector fragments using in-fusion cloning. </p>
+
<p>The purified fragments were analyzed by electrophoresis on 1% agarose gels stained with with YeaRed Nucleic Acid Gel Stain(Fig. 2).  The Mfp6 fragment was inserted into the pET-28a(+) vector fragments using in-fusion cloning. </p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 72: Line 72:
 
     <div class="module">
 
     <div class="module">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-pet28a-pcr.webp" width="350" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-pet28a-pcr.webp" width="350" height="auto" alt="Protein purification">
         <p><b>Fig. 2 | 1 % agarose gel electrophoresis of the PCR amplified Mfp6 and pET28a(+) vector.</b></p>
+
         <p><b>Fig. 2 | 1 % agarose gel electrophoresis of the PCR amplified Mfp6 and pET-28a(+) vector.</b></p>
         <p>Line 1:5000 bp DNA Marker; Lines 2,3: the PCR amplified Mfp6(363 bp). Lines 4,5: the PCR amplified pET28a(+) vector(5725 bp).</p>
+
         <p>Lane 1: 5000 bp DNA Marker; Lanes 2,3: the PCR amplified Mfp6(363 bp); Lanes 4,5: the PCR amplified pET-28a(+) vector(5725 bp).</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
===Transformation and Colony PCR ===
 
===Transformation and Colony PCR ===
<p>The final plasmid named pET-28a(+)-Mfp6 assembly underwent transformation into <i>E.coli</i> DH5a competent cells and then colony PCR was performed, using T7 and Mfp6 bottom primers(Tab. 1). For the colony PCR procedure, from the agar plate half amount of each colony was picked and diluted on 10 μL of doble distilled wate. 1 μL was used for sample preparation, while the remainder was used for liquid culture. The samples were loaded and run in 1% agarose gel electrophoresis and then we concluded that the recombination was successful(Fig. 3). </p>
+
<p>The final plasmid named pET-28a(+)-Mfp6 assembly underwent transformation into <i>E.coli</i> DH5a competent cells and then colony PCR was performed, using T7 universal primer and Mfp6 bottom primers(Tab. 1). For the colony PCR procedure, from the agar plate half amount of each colony was picked and diluted on 10 μL of doble distilled wate. 1 μL was used for sample preparation, while the remainder was used for liquid culture. The samples were loaded and run in 1% agarose gel electrophoresis and then we concluded that the recombination was successful(Fig. 3). </p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 98: Line 99:
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/pet28a-mfp6-map-p222.webp" width="700" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/pet28a-mfp6-map-p222.webp" width="700" height="auto" alt="Protein purification">
 
         <p><b>Fig. 3 | The results of transformation and colony PCR.</b>
 
         <p><b>Fig. 3 | The results of transformation and colony PCR.</b>
         <p><b>a.</b>The plasmid map of pET28a(+)-Mfp6.<b>b.</b>Colony PCR of E-coli DH5a transformants using T7 and Mfp6-bottom primers.Line 1: 2000 bp DNA Marker; Lines 2-9: pET28a(+)-Mfp6 using T7 and Mfp6-bottom primers (912 bp) from different colonies.</p>
+
         <p><b>a.</b>The plasmid map of pET28a(+)-Mfp6. <b>b.</b>Colony PCR of <i>E-coli</i> DH5a transformants using T7 universal primer and Mfp6-bottom primer. Lane 1: 2000 bp DNA Marker; Lanes 2-9: pET28a(+)-Mfp6 using T7 and Mfp6-bottom primers (912 bp) from different colonies.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
===Sequencing===
 
===Sequencing===
<p>We selected colonies from Line 3 and Line 4 and performed overnight cultures in tubes containing 5 mL of LB medium. Subsequently, we extracted the plasmids using the FastPure Plasmid Mini kit and submitted them for sequencing. The sequencing result shows there was a synonymous mutation at the SUMO-tag site which did not influence the structure and function of Mfp6, while other sequences appeared normal.(Fig. 4).</p>
+
<p>We selected colonies from Lane 3 and Lane 4 and performed overnight cultures in tubes containing 5 mL of LB medium. Subsequently, we extracted the plasmids using the FastPure Plasmid Mini kit and submitted them for sequencing. The sequencing result shows there was a synonymous mutation at the SUMO-tag site which did not influence the structure and function of Mfp6, while other sequences appeared normal.(Fig. 4).</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 121: Line 123:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/pet28a-mfp6-map-png.webp" width="800" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/pet28a-mfp6-map444.webp" width="800" height="auto" alt="Protein purification">
 
         <p><b>Fig. 4 | Result of pET28a(+)-Mfp6 sequencing.</b></p>
 
         <p><b>Fig. 4 | Result of pET28a(+)-Mfp6 sequencing.</b></p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
==Cultivation, Purification and SDS-PAGE==
 
==Cultivation, Purification and SDS-PAGE==
 
===Shaking Flask Cultivations===
 
===Shaking Flask Cultivations===
Line 148: Line 151:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
        <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-png.webp" width="500" height="auto" alt="Protein purification">
+
          <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6-wb-sds.webp" width="800" height="auto" alt="Protein purification">
         <p><b>Fig. 5 | SDS-PAGE of pET28a(+)-Mfp6(28 kDa).</b></p>
+
         <p><b>Fig. 5 | Expression of pET-28a(+)-Mfp6(28 kDa).</b></p>
         <p>Line 1: Protein Marker; Line 2: Mfp6-Whole Cell Lysate(IPTG); Line 3: Mfp6-Supernatant(IPTG); Line 4: Mfp6-Pellet-PBS(IPTG); Line 5:Mfp6-Pellet-Extraction buffer(IPTG); Line 6: Mfp6-Whole Cell Lysate-1; Line 7: Mfp6-Supernatant-1; Line 8: Mfp6-Pellet-PBS-1. Line 9:Mfp6-Pellet-Extraction buffer-1; Line 10: Mfp6-Whole Cell Lysate-2; Line 11: Mfp6-Supernatant-2; Line 12: Mfp6-Pellet-PBS-2; Line 13:Mfp6-Pellet-Extraction buffer-2.</p>
+
         <p><b>a.</b>SDS-PAGE of pET28a(+)-Mfp6(28 kDa). Lane 1: Protein Marker; Lane 2: Mfp6-Whole Cell Lysate(IPTG); Lane 3: Mfp6-Supernatant(IPTG); Lane 4: Mfp6-Pellet-PBS(IPTG); Lane 5: Mfp6-Pellet-Extraction Buffer(IPTG); Lane 6: Mfp6-Whole Cell Lysate-1; Lane 7: Mfp6-Supernatant-1; Lane 8: Mfp6-Pellet-PBS-1; Lane 9: Mfp6-Pellet-Extraction Buffer-1; Lane 10: Mfp6-Whole Cell Lysate-2; Lane 11: Mfp6-Supernatant-2; Lane 12: Mfp6-Pellet-PBS-2; Lane 13: Mfp6-Pellet-Extraction Buffer-2. <b>b.</b>Western blot of pET-28a(+)-Mfp6(28 kDa). Lane 1: Mfp6-Whole Cell Lysate(IPTG); Lane 2: Mfp6-Supernatant(IPTG); Lane 3: Mfp6-Pellet-PBS(IPTG).</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
===Shaking Flask Cultivations===
 
===Shaking Flask Cultivations===
 
<p>To obtain a larger quantity of protein, we cultured the target strain using the same method as described above, but with a 500 mL volume of LB medium.</p>
 
<p>To obtain a larger quantity of protein, we cultured the target strain using the same method as described above, but with a 500 mL volume of LB medium.</p>
 
===Purification and SDS-PAGE===
 
===Purification and SDS-PAGE===
<p>Mfp6 was extracted from the pellet with Extraction Buffer (5% v/v acetic acid, 50 mM DTT, 8 M urea) and the supernatant was dialyzed overnight against 5% v/v acetic acid in a total volume ratio of 1:1200. Then, we used a Hypur T Ni-NTA 6FF (His-Tag) Prepacked Chromatographic Column, 1mL for immobilized metal affinity chromatography (IMAC) purification of the samples. First, the column was equilibrated with 5 resin volumes of washing bufferand then loaded with 5 mL of the resuspended denatured samples. Target recombinant Mfp6 was eluted with Elution buffer (50 mM Na2HPO4, 8 M Urea, 100 mM NaCl, 250 mM Imidazole, pH 7.4)(Fig. 6). Eluted Mfp6 was dialyzed in 5 % v/v acetic acid overnight at 4°C, stored at -20℃.</p>
+
<p>Mfp6 was extracted from the pellet with Extraction Buffer (5% v/v acetic acid, 50 mM DTT, 8 M urea) and the supernatant was dialyzed overnight against 5% v/v acetic acid in a total volume ratio of 1:1200. Then, we used a Hypur T Ni-NTA 6FF (His-Tag) Prepacked Chromatographic Column, 1mL for immobilized metal affinity chromatography (IMAC) purification of the samples. First, the column was equilibrated with 5 resin volumes of washing buffer and then loaded with 5 mL of the resuspended denatured samples. Target recombinant Mfp6 was eluted with Elution Buffer (50 mM Na<sub>2</sub>HPO<sub>4</sub>, 8 M Urea, 100 mM NaCl, 250 mM Imidazole, pH 7.4)(Fig. 6). Eluted Mfp6 was dialyzed in 5 % v/v acetic acid overnight at 4°C, stored at -20℃.</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 176: Line 180:
 
     <div class="module">
 
     <div class="module">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6111-9-6.webp" width="350" height="auto" alt="Protein purification">
 
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/mfp6111-9-6.webp" width="350" height="auto" alt="Protein purification">
         <p><b>Fig. 6 | SDS-PAGE of pET28a(+)-Mfp6(28 kDa).</b></p>
+
         <p><b>Fig. 6 | SDS-PAGE of pET-28a(+)-Mfp6(28 kDa).</b></p>
         <p>Line 1: Protein Marker; Line 2: Extraction Buffer; Line 3: Supernatant; Line 4: Elution Buffer(50 mM Imidazole); Line 5: Elution Buffer(100 mM Imidazole); Line 6: Elution Buffer(250 mM Imidazole); Line 7: Elution Buffer(500 mM Imidazole).</p>
+
         <p>Lane 1: Protein Marker; Lane 2: Extraction Buffer; Lane 3: Supernatant; Lane 4: Elution Buffer(50 mM Imidazole); Lane 5: Elution Buffer(100 mM Imidazole); Lane 6: Elution Buffer(250 mM Imidazole); Lane 7: Elution Buffer(500 mM Imidazole).</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
==Activity Analysis of Mfp6==
 
==Activity Analysis of Mfp6==
 
===Activity analysis at different substrate concentrations===
 
===Activity analysis at different substrate concentrations===
<p>We conducted the reaction with varying concentrations of tyrosine as the substrate, adding an equal and sufficient amount of tyrosinase TyrVs to each well. The mixture was incubated at 37°C to allow for a full 30-minute reaction. Subsequently, an equal and excess amount of Mfp6 was added, and the reaction was allowed to proceed for an additional 5 min. The absorbance at 475 nm was then measured using a microplate reader. As depicted in Fig. 7, the OD values of the experimental group were consistently lower than those of the control group across all concentrations. Besides, an increasingly obvious colour occurs in experimental group compared to control group along with the increase of concentration. This suggests that Mfp6 indeed reduced some of the dopaquinone back to DOPA, with the reduction effect being more pronounced at higher substrate concentrations.</p>
+
<p>We conducted the reaction with varying concentrations of tyrosine as the substrate, adding an equal and sufficient amount of tyrosinase TyrVs to each well. The mixture was incubated at 37°C to allow for a full 30-min reaction. Subsequently, an equal and excess amount of Mfp6 was added, and the reaction was allowed to proceed for an additional 5 min. The absorbance at 475 nm was then measured using a microplate reader. As depicted in Fig. 7, the OD values of the experimental group were consistently lower than those of the control group across all concentrations. Besides, an increasingly obvious colour occurs in experimental group compared to control group along with the increase of concentration. This suggests that Mfp6 indeed reduced some of the dopaquinone back to L-DOPA, with the reduction effect being more pronounced at higher substrate concentrations.</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 201: Line 206:
 
<body>
 
<body>
 
     <div class="module">
 
     <div class="module">
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/od-96-2222.webp" width="800" height="auto" alt="Protein purification">
+
         <img src="https://static.igem.wiki/teams/5398/mfp6-picture/od-96-444.webp" width="800" height="auto" alt="Protein purification">
 
         <p><b>Fig. 7 | Result of Activity analysis.</b></p>
 
         <p><b>Fig. 7 | Result of Activity analysis.</b></p>
         <p><b>a.</b>Mfp6 Activity analysis at different substrate concentrations.<b>b.</b>Mfp6 Activity Analysis on a 96-Well Plate.</p>
+
         <p><b>a.</b>Mfp6 Activity analysis at different substrate concentrations. <b>b.</b>Mfp6 Activity Analysis on a 96-Well Plate.</p>
 
     </div>
 
     </div>
 
</body>
 
</body>
 
</html>
 
</html>
 +
 
===Activity analysis at different reaction time===
 
===Activity analysis at different reaction time===
<p>We utilized 750 μM tyrosine as the substrate in the reaction, adding an equal and appropriate amount of tyrosinase TyrVs to each well. The reaction was allowed to proceed at 37°C for a full 30 min. Following this, an equal and excess amount of Mfp6 was introduced, and the absorbance at 475 nm was measured at 30-second intervals using a microplate reader. As shown in Fig. 8, the OD values of the experimental group gradually decreased over time, while those of the control group remained virtually unchanged. This indicates that Mfp6 progressively reduced dopaquinone back to DOPA as the reaction progressed. Additionally, the difference in OD values between the experimental and control groups at the zero-minute mark may be attributed to unavoidable errors such as variations in sample addition time.</p>
+
<p>We utilized 750 μM tyrosine as the substrate in the reaction, adding an equal and appropriate amount of tyrosinase TyrVs to each well. The reaction was allowed to proceed at 37°C for a full 30 min. Following this, an equal and excess amount of Mfp6 was introduced, and the absorbance at 475 nm was measured at 30-sec intervals using a microplate reader. As shown in Fig. 8, the OD values of the experimental group gradually decreased over time, while those of the control group remained virtually unchanged. This indicates that Mfp6 progressively reduced dopaquinone back to L-DOPA as the reaction progressed.</p>
 
<html lang="zh">
 
<html lang="zh">
 
<head>
 
<head>
Line 231: Line 237:
 
</body>
 
</body>
 
</html>
 
</html>
 +
<!-- -->
 +
<span class='h3bb'>Sequence and Features</span>
 +
<partinfo>BBa_K5398601 SequenceAndFeatures</partinfo>
 
=Reference=
 
=Reference=
<p>[1] Nicklisch SC, Das S, Martinez Rodriguez NR, et al. Antioxidant efficacy and adhesion rescue by a recombinant mussel foot protein-6[J]. <i>Biotechnol Prog</i>, 2013, 29(6):1587-1593. </p>
+
<p>[1] Nicklisch SC, Das S, Martinez Rodriguez NR, et al. Antioxidant efficacy and adhesion rescue by a recombinant mussel foot protein-6[J]. <i>Biotechnol Prog.</i>, 2013, 29(6):1587-1593. </p>
 
<p>[2] TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized Verrucomicrobium spinosum tyrosinase on polyhydroxyalkanoate nano-granules [J]. <i>Appl. Microbiol. Biotechnol.</i>, 2019, 103(14): 5663-78.</p>
 
<p>[2] TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized Verrucomicrobium spinosum tyrosinase on polyhydroxyalkanoate nano-granules [J]. <i>Appl. Microbiol. Biotechnol.</i>, 2019, 103(14): 5663-78.</p>
 
<p>[3] YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. <i>Int. J. Biol. Macromol.</i>, 2022, 195: 229-36.</p>
 
<p>[3] YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. <i>Int. J. Biol. Macromol.</i>, 2022, 195: 229-36.</p>

Latest revision as of 08:56, 2 October 2024

Introduction

Mussel foot protein type 6 (Mfp6)(BBa_K5398601), which has a molecular weight of 13.8 kDa, is a protein found in the byssal gland cells of mussels. It belongs to the family of mussel foot proteins and plays a crucial role in maintaining the reducing conditions necessary for optimal wet adhesion in marine mussels. Mfp6(BBa_K5398601) is particularly rich in cysteine, a sulfur-containing amino acid that can form stable structures in mussel adhesion proteins and provide antioxidant protection. This antioxidant property helps prevent second-oxidation of Levodopa (L-DOPA) residues in adhesion proteins, thereby maintaining their adhesive function.

During the adhesion process of mussels, Mfp6(BBa_K5398601) may work in conjunction with other foot proteins, such as Mfp3 and Mfp5, which are rich in L-DOPA and are key factors in the adhesive strength of mussel adhesion proteins. Mfp6(BBa_K5398601), through its antioxidant properties, helps protect L-DOPA residues at the initial stage of adhesion, thus maintaining the protein's adhesive ability. In addition, Mfp6(BBa_K5398601) may also regulate the tautomeric balance of adhesion proteins, further affecting adhesion performance.

Usage and Biology

Mfp6(BBa_K5398601) is a improtant part of the Tyrosinase Catalysis System.When tyrosinase TyrVs(BBa_K5398600) causes excessive oxidation of tyrosine on the fusion protein TRn4-Mfp5(BBa_K5398020) to form dopaquinone, the Mfp6 protein(BBa_K5398601) can reduce the excessively oxidized dopaquinone back to L-DOPA, thereby enhancing the adhesive performance of the fusion protein TRn4-Mfp5(BBa_K5398020).

Protein purification

Fig. 1 | Mechanism of action.

Characterization

Strains and Plasmid Construction

Plasmid Construction

The Mfp6 sequence(363 bp) was cloned from the pETDuet-1-Mfp6 vector using a polymerase chain reaction(PCR) method. Specific primers were synthesized for PCR amplification(Table 1). The forward primer was designated as Mfp6-top, and the reverse primer as Mfp6-bottom. These primers, along with 2×Phanta Max Master Mix (Dye Plus), were used in a PCR reaction for 30 cycles with a temperature profile of 15 sec at 95°C, 15 sec at 56°C, and 1 min at 72°C.

Similarly, the pET-28a(+) sequence(5725 bp) was cloned from the pET-28a(+)-TRn4-Mfp5 vector. The forward primer was pET-28a(+)-top and the reverse primer was pET-28a(+)-bottom(Table 1). Polymerase Chain Reaction(PCR) was performed for 30 cycles with a temperature profile of 95°C for 15 sec, 67°C for 15 sec, and 72°C for 1 min.

Table 1 | Details of Plasmids、Fragments and Primers.

Protein purification

The purified fragments were analyzed by electrophoresis on 1% agarose gels stained with with YeaRed Nucleic Acid Gel Stain(Fig. 2). The Mfp6 fragment was inserted into the pET-28a(+) vector fragments using in-fusion cloning.

Protein purification

Fig. 2 | 1 % agarose gel electrophoresis of the PCR amplified Mfp6 and pET-28a(+) vector.

Lane 1: 5000 bp DNA Marker; Lanes 2,3: the PCR amplified Mfp6(363 bp); Lanes 4,5: the PCR amplified pET-28a(+) vector(5725 bp).

Transformation and Colony PCR

The final plasmid named pET-28a(+)-Mfp6 assembly underwent transformation into E.coli DH5a competent cells and then colony PCR was performed, using T7 universal primer and Mfp6 bottom primers(Tab. 1). For the colony PCR procedure, from the agar plate half amount of each colony was picked and diluted on 10 μL of doble distilled wate. 1 μL was used for sample preparation, while the remainder was used for liquid culture. The samples were loaded and run in 1% agarose gel electrophoresis and then we concluded that the recombination was successful(Fig. 3).

Protein purification

Fig. 3 | The results of transformation and colony PCR.

a.The plasmid map of pET28a(+)-Mfp6. b.Colony PCR of E-coli DH5a transformants using T7 universal primer and Mfp6-bottom primer. Lane 1: 2000 bp DNA Marker; Lanes 2-9: pET28a(+)-Mfp6 using T7 and Mfp6-bottom primers (912 bp) from different colonies.

Sequencing

We selected colonies from Lane 3 and Lane 4 and performed overnight cultures in tubes containing 5 mL of LB medium. Subsequently, we extracted the plasmids using the FastPure Plasmid Mini kit and submitted them for sequencing. The sequencing result shows there was a synonymous mutation at the SUMO-tag site which did not influence the structure and function of Mfp6, while other sequences appeared normal.(Fig. 4).

Protein purification

Fig. 4 | Result of pET28a(+)-Mfp6 sequencing.

Cultivation, Purification and SDS-PAGE

Shaking Flask Cultivations

E. coli BL21(DE3) having the pET-28a(+)-Mfp6 plasmid was grown in a shaking flask containing 50 mL of LB medium and the culture conditions were set at 37℃ with shaking at 250 rpm. Cell growth was monitored by measuring the optical density at 600 nm (OD600) using a Nanodrop. When the OD600 reached 0.6 to 0.8, 10 μM IPTG (final concentration) was added to the culture to induce the expression of the recombinant Mfp6 protein. After induction, the cells were further cultivated at 37℃ for 5 h before being centrifuged and lysed.

SDS-PAGE

From Fig. 5, we can know the Mfp6 protein with a molecular weight of 28 kDa was predominantly enriched in the pellet fraction, with the best results obtained when using Extraction Buffer(5% v/v acetic acid, 50 mM DTT, 8 M urea) as the lysis buffer.

Protein purification

Fig. 5 | Expression of pET-28a(+)-Mfp6(28 kDa).

a.SDS-PAGE of pET28a(+)-Mfp6(28 kDa). Lane 1: Protein Marker; Lane 2: Mfp6-Whole Cell Lysate(IPTG); Lane 3: Mfp6-Supernatant(IPTG); Lane 4: Mfp6-Pellet-PBS(IPTG); Lane 5: Mfp6-Pellet-Extraction Buffer(IPTG); Lane 6: Mfp6-Whole Cell Lysate-1; Lane 7: Mfp6-Supernatant-1; Lane 8: Mfp6-Pellet-PBS-1; Lane 9: Mfp6-Pellet-Extraction Buffer-1; Lane 10: Mfp6-Whole Cell Lysate-2; Lane 11: Mfp6-Supernatant-2; Lane 12: Mfp6-Pellet-PBS-2; Lane 13: Mfp6-Pellet-Extraction Buffer-2. b.Western blot of pET-28a(+)-Mfp6(28 kDa). Lane 1: Mfp6-Whole Cell Lysate(IPTG); Lane 2: Mfp6-Supernatant(IPTG); Lane 3: Mfp6-Pellet-PBS(IPTG).

Shaking Flask Cultivations

To obtain a larger quantity of protein, we cultured the target strain using the same method as described above, but with a 500 mL volume of LB medium.

Purification and SDS-PAGE

Mfp6 was extracted from the pellet with Extraction Buffer (5% v/v acetic acid, 50 mM DTT, 8 M urea) and the supernatant was dialyzed overnight against 5% v/v acetic acid in a total volume ratio of 1:1200. Then, we used a Hypur T Ni-NTA 6FF (His-Tag) Prepacked Chromatographic Column, 1mL for immobilized metal affinity chromatography (IMAC) purification of the samples. First, the column was equilibrated with 5 resin volumes of washing buffer and then loaded with 5 mL of the resuspended denatured samples. Target recombinant Mfp6 was eluted with Elution Buffer (50 mM Na2HPO4, 8 M Urea, 100 mM NaCl, 250 mM Imidazole, pH 7.4)(Fig. 6). Eluted Mfp6 was dialyzed in 5 % v/v acetic acid overnight at 4°C, stored at -20℃.

Protein purification

Fig. 6 | SDS-PAGE of pET-28a(+)-Mfp6(28 kDa).

Lane 1: Protein Marker; Lane 2: Extraction Buffer; Lane 3: Supernatant; Lane 4: Elution Buffer(50 mM Imidazole); Lane 5: Elution Buffer(100 mM Imidazole); Lane 6: Elution Buffer(250 mM Imidazole); Lane 7: Elution Buffer(500 mM Imidazole).

Activity Analysis of Mfp6

Activity analysis at different substrate concentrations

We conducted the reaction with varying concentrations of tyrosine as the substrate, adding an equal and sufficient amount of tyrosinase TyrVs to each well. The mixture was incubated at 37°C to allow for a full 30-min reaction. Subsequently, an equal and excess amount of Mfp6 was added, and the reaction was allowed to proceed for an additional 5 min. The absorbance at 475 nm was then measured using a microplate reader. As depicted in Fig. 7, the OD values of the experimental group were consistently lower than those of the control group across all concentrations. Besides, an increasingly obvious colour occurs in experimental group compared to control group along with the increase of concentration. This suggests that Mfp6 indeed reduced some of the dopaquinone back to L-DOPA, with the reduction effect being more pronounced at higher substrate concentrations.

Protein purification

Fig. 7 | Result of Activity analysis.

a.Mfp6 Activity analysis at different substrate concentrations. b.Mfp6 Activity Analysis on a 96-Well Plate.

Activity analysis at different reaction time

We utilized 750 μM tyrosine as the substrate in the reaction, adding an equal and appropriate amount of tyrosinase TyrVs to each well. The reaction was allowed to proceed at 37°C for a full 30 min. Following this, an equal and excess amount of Mfp6 was introduced, and the absorbance at 475 nm was measured at 30-sec intervals using a microplate reader. As shown in Fig. 8, the OD values of the experimental group gradually decreased over time, while those of the control group remained virtually unchanged. This indicates that Mfp6 progressively reduced dopaquinone back to L-DOPA as the reaction progressed.

Protein purification

Fig. 8 | Mfp6 Activity analysis at different reaction time.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Reference

[1] Nicklisch SC, Das S, Martinez Rodriguez NR, et al. Antioxidant efficacy and adhesion rescue by a recombinant mussel foot protein-6[J]. Biotechnol Prog., 2013, 29(6):1587-1593.

[2] TAN D, ZHAO J P, RAN G Q, et al. Highly efficient biocatalytic synthesis of L-DOPA using in situ immobilized Verrucomicrobium spinosum tyrosinase on polyhydroxyalkanoate nano-granules [J]. Appl. Microbiol. Biotechnol., 2019, 103(14): 5663-78.

[3] YAO L, WANG X, XUE R, et al. Comparative analysis of mussel foot protein 3B co-expressed with tyrosinases provides a potential adhesive biomaterial [J]. Int. J. Biol. Macromol., 2022, 195: 229-36.